Fairvalue-Calculator Fairvalue-Calculator
EN DE

Dogecoin Cash, Inc (DOGP) Fair Value & Analysis

Healthcare · US · Market cap $1.3M

Price$0.0075
Fair Value$0.0100
Upside+33.3%
Quality80/100
Evidence: Low Range $0.0100 – $0.0100

Fair value as of: Jun 23, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Dogecoin Cash, Inc (DOGP) currently trades at $0.0075, while our model-based Fair Value estimate is $0.0100 — implying the stock looks roughly 33.3% undervalued today. We read business quality at 80/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

Dogecoin Cash, Inc., through its subsidiaries, provides online telehealth referral services through the PrestoDoctor platform in the United States. The company offers the technology platform and administrative support that facilitate telemedicine consultations between patients and licensed physicians. In addition, it maintains cannabis-related intellectual property. The company was formerly known as Cannabis Sativa, Inc. and changed its name to Dogecoin Cash, Inc. in November 2024. Dogecoin Cash, Inc. is based in Mesquite, Nevada.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Dogecoin Cash, Inc (DOGP) undervalued?
As of Jun 23, 2026, our model estimates a fair value of $0.0100 versus a price of $0.0075 — about +33% (undervalued). Model-based estimate, not financial advice.
What is the fair value of DOGP?
Our 21-model fair value for Dogecoin Cash, Inc is $0.0100 (as of Jun 23, 2026), built from audited fundamentals. The current price is $0.0075.
What is the quality score of DOGP?
Dogecoin Cash, Inc has a Quality Score of 80/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.